The Asia Pacific Cardiovascular Ultrasound Market would witness market growth of 11.6% CAGR during the forecast period (2021-2027).
Cardiovascular diseases (CVD) are the leading reason for morbidity and mortality in well-established countries. CVDs are the major cause of death in emerging nations. According to the World Health Organization (WHO), 16% of global deaths are due to ischemic heart disease. Additionally, the growing cases of cardiovascular diseases have fueled the demand for the cardiovascular ultrasound system in the last couple of years.
Constant technological up-gradation like artificial intelligence has a bright impact on cardiology with advanced abilities to diagnose some heart conditions. For example, GE Healthcare got the US FDA 510k approval for its ultra-edition package of vivid cardiovascular ultrasound systems in October 2020. These systems involve the latest features on the basis of artificial intelligence (AI) that allow doctors to obtain rapid, more repetitive exams constantly.
The region is witnessing high demand for a portable ultrasound due to the rise in preference for minimally invasive surgeries. Portable ultrasound has various uses in point-of-care treatments, home, and emergency rooms. Hospitals and other healthcare vendors are shifting from traditional to portable and handheld ultrasound imaging devices because of the simple utilization and accuracy.
In addition, the region is currently witnessing huge demand for the minimally invasive device, increasing geriatric population, reduction in the size of ultrasound devices, and rising cases of chronic diseases such as cancer are some of the prime factors boosting the growth of the European ultrasound devices market.
The China market dominated the Asia Pacific Fetal echocardiography Market by Country 2020, thereby, achieving a market value of $51 million by 2027. The Japan market is showcasing a CAGR of 11.7% during (2021 - 2027). Additionally, The India market is poised to witness a CAGR of 13.5% during (2021 - 2027).
Based on Display, the market is segmented into Color Display and B/W Display. Based on Technology, the market is segmented into Doppler, 2D and 3D/4D. Based on Type, the market is segmented into Transthoracic echocardiography, Transesophageal echocardiography, Fetal echocardiography and Others. Based on End Use, the market is segmented into Hospital, Diagnostic centers, Ambulatory care centers and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Cardiovascular Ultrasound Market is Projected to reach USD 2.6 Billion by 2027, at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens AG (Siemens Healthineers), Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation) and Esaote SpA.
By Display
By Technology
By Type
By End Use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
